Page 408 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 408
University of Liverpool 200 A
70 Pembroke Place
Liverpool, L69 3GF
United Kingdom
www.hep-druginteractions.org
www.hep-druginteractions.org was launched in 2011 by the University of Liverpool to
provide up to date drug interaction information allowing users to build interaction tables for
hepatitis therapies with commonly prescribed co-medications.The website, along with HEP
iChart (the associated free app for Apple and Android), offers health care professionals,
researchers and patients a resource to understand and manage interactions. Advice is
displayed in a “traffic lights” format – green (no clinically significant interaction expected),
amber (potential interaction which may be tolerated if benefits outweigh risk, and the
interaction can be managed/monitored), red (drugs should not be coadministered).
World Hepatitis Alliance 410 H
86 bis, route de Frontenex
Geneva, 6364
Switzerland
www.worldhepatitisalliance.org
The World Hepatitis Alliance is a not-for-profit international umbrella NGO. Our
membership is composed of approximately 200 organisations working in the field of viral
hepatitis, representing every region of the world. We are patient-led & patient-driven, and
our voting membership is limited to patient groups which means we are the global voice for
the 400 million people worldwide living with viral hepatitis. We provide global leadership
& support action that will halt the viral hepatitis death toll & improve lives. Our ultimate
goal is to work with our members, governments & other key partners to eradicate hepatitis
from the planet.
INDUSTRY INFORMATION
408 The International Liver Congress™ 2015 • ILC Programme
70 Pembroke Place
Liverpool, L69 3GF
United Kingdom
www.hep-druginteractions.org
www.hep-druginteractions.org was launched in 2011 by the University of Liverpool to
provide up to date drug interaction information allowing users to build interaction tables for
hepatitis therapies with commonly prescribed co-medications.The website, along with HEP
iChart (the associated free app for Apple and Android), offers health care professionals,
researchers and patients a resource to understand and manage interactions. Advice is
displayed in a “traffic lights” format – green (no clinically significant interaction expected),
amber (potential interaction which may be tolerated if benefits outweigh risk, and the
interaction can be managed/monitored), red (drugs should not be coadministered).
World Hepatitis Alliance 410 H
86 bis, route de Frontenex
Geneva, 6364
Switzerland
www.worldhepatitisalliance.org
The World Hepatitis Alliance is a not-for-profit international umbrella NGO. Our
membership is composed of approximately 200 organisations working in the field of viral
hepatitis, representing every region of the world. We are patient-led & patient-driven, and
our voting membership is limited to patient groups which means we are the global voice for
the 400 million people worldwide living with viral hepatitis. We provide global leadership
& support action that will halt the viral hepatitis death toll & improve lives. Our ultimate
goal is to work with our members, governments & other key partners to eradicate hepatitis
from the planet.
INDUSTRY INFORMATION
408 The International Liver Congress™ 2015 • ILC Programme
